X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (156) 156
humans (126) 126
pharmacology & pharmacy (93) 93
medicine & public health (70) 70
pharmacology/toxicology (62) 62
animals (59) 59
nonsteroidal antiinflammatory drugs (59) 59
cyclo-oxygenase 2 (51) 51
female (51) 51
male (48) 48
cyclooxygenase 2 (46) 46
celecoxib (44) 44
cyclo-oxygenase-2 (44) 44
internal medicine (43) 43
pharmacotherapy (43) 43
rheumatoid-arthritis (43) 43
aged (40) 40
cyclo‐oxygenase‐2 (40) 40
cyclo oxygenase 2 inhibitors (39) 39
toxicology (37) 37
membrane proteins (33) 33
rofecoxib (31) 31
anti-inflammatory agents, non-steroidal - adverse effects (30) 30
cyclooxygenase-2 (30) 30
cyclooxygenase inhibitors - therapeutic use (29) 29
middle aged (28) 28
nonsteroidal anti inflammatories (26) 26
biochemistry & molecular biology (25) 25
cyclooxygenase 2 inhibitors (25) 25
cyclooxygenase 2 - metabolism (24) 24
prostaglandin-endoperoxide synthases - metabolism (24) 24
expression (23) 23
public, environmental & occupational health (23) 23
cyclooxygenase inhibitors - adverse effects (22) 22
drug safety and pharmacovigilance (22) 22
isoenzymes - metabolism (22) 22
anti-inflammatory agents, non-steroidal - therapeutic use (21) 21
rats (21) 21
adult (19) 19
cox-2 inhibitors (19) 19
cyclooxygenase 2 inhibitors - adverse effects (19) 19
dose-response relationship, drug (19) 19
gastrointestinal toxicity (19) 19
osteoarthritis (19) 19
sulfonamides - adverse effects (19) 19
risk (18) 18
cyclooxygenase inhibitors - pharmacology (17) 17
lactones - adverse effects (16) 16
mice (16) 16
cancer (14) 14
clinical trials as topic (14) 14
cox-2 (14) 14
cyclo oxygenase 2 inhibitors, adverse reactions (14) 14
cyclo oxygenase 2 inhibitors, therapeutic use (14) 14
cyclooxygenase-2 expression (14) 14
inflammation (14) 14
prostaglandins (14) 14
sulfones - adverse effects (14) 14
cyclo oxygenase 2 inhibitors, general (13) 13
isoenzymes - antagonists & inhibitors (13) 13
papers (13) 13
postoperative pain, treatment (13) 13
pyrazoles (13) 13
risk factors (13) 13
apoptosis (12) 12
cyclo-oxygenase 2 inhibitors (12) 12
cyclooxygenase 2 inhibitors - pharmacology (12) 12
rna, messenger - metabolism (12) 12
cyclooxygenase-2 inhibitors (11) 11
double-blind (11) 11
elderly (11) 11
lactones - therapeutic use (11) 11
messenger-rna (11) 11
nonsteroidal anti-inflammatory drugs (11) 11
prostaglandin (11) 11
sulfones (11) 11
time factors (11) 11
aged, 80 and over (10) 10
cells, cultured (10) 10
cyclooxygenase 2 inhibitors - therapeutic use (10) 10
gastroenterology & hepatology (10) 10
gene-expression (10) 10
necrosis-factor-alpha (10) 10
osteoarthritis, treatment (10) 10
randomized controlled-trial (10) 10
research and development (10) 10
rheumatoid arthritis, treatment (10) 10
sulfonamides - pharmacology (10) 10
sulfonamides - therapeutic use (10) 10
sulfones - therapeutic use (10) 10
up-regulation (10) 10
antiinflammatory drugs (9) 9
blotting, western (9) 9
cardiovascular diseases - chemically induced (9) 9
cells (9) 9
cyclooxygenase-2 inhibitor (9) 9
epithelial-cells (9) 9
geriatrics & gerontology (9) 9
geriatrics/gerontology (9) 9
induction (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, ISSN 1044-1549, 01/2016, Volume 54, Issue 1, pp. 128 - 135
Tachyphylaxis of the beta(2)-adrenergic receptor limits the efficacy of bronchodilatory beta(2)-agonists in respiratory disease. Cellular studies in airway... 
INTERLEUKIN-1-BETA | BIOCHEMISTRY & MOLECULAR BIOLOGY | beta-adrenergic receptor desensitization | INDUCTION | prostaglandin E-2 | CELL BIOLOGY | COX-2 EXPRESSION | AIRWAY | cyclic adenosine monophosphate | RESPIRATORY SYSTEM | INFLAMMATION | SPHINGOSINE-1-PHOSPHATE | EXACERBATIONS | ASTHMA | SMOOTH-MUSCLE-CELLS | sphingosine 1-phosphate | cyclo-oxygenase 2
Journal Article
STEM CELLS, ISSN 1066-5099, 09/2016, Volume 34, Issue 9, pp. 2290 - 2305
Cancer stem‐like cells (SLC) resist conventional therapies, necessitating searches for SLC‐specific targets. We established that cyclo‐oxygenase(COX)‐2... 
EP4 | NOTCH/WNT | Breast cancer | Stem‐like cell | Cyclo‐oxygenase‐2 | Cyclo-oxygenase-2 | Stem-like cell | MIGRATION | TARGET | CYCLOOXYGENASE-2 | ANGIOGENESIS | CELL & TISSUE ENGINEERING | CELL BIOLOGY | PROSTANOID RECEPTORS | ONCOLOGY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GROWTH | LYMPHANGIOGENESIS | INHIBITORS | HEMATOLOGY | EXPRESSION | Signal Transduction | Neoplasm Invasiveness | Receptors, Notch - metabolism | Humans | RNA, Messenger - genetics | Gene Expression Regulation, Neoplastic | Phosphatidylinositol 3-Kinases - metabolism | RNA, Messenger - metabolism | Wnt Proteins - metabolism | Breast Neoplasms - enzymology | Phenotype | Animals | Breast Neoplasms - genetics | Neoplastic Stem Cells - metabolism | Breast Neoplasms - pathology | Cyclooxygenase 2 - metabolism | Cell Line, Tumor | Neoplastic Stem Cells - pathology | Female | Mice | Proto-Oncogene Proteins c-akt - metabolism | Neoplasm Micrometastasis - pathology | Receptors, Prostaglandin E, EP4 Subtype - metabolism | COX-2 inhibitors | Prostaglandins | DNA microarrays | Endothelial growth factors | RNA | Analysis | Stem cells | Development and progression | Transplantation | Metastasis | Intermediate filament proteins | Genes | Rodents | Regulations | Severe combined immunodeficiency | Leukocyte migration | Mesenchyme | Oct-4 protein | Lung | Gene regulation | AKT protein | E-cadherin | Prostaglandin endoperoxide synthase | Metastases | Allografts | CD44 antigen | Animal tissues | Down-regulation | Localization | Vascular endothelial growth factor | Interleukin 2 receptors | Markers | Gene expression | Spheroids | 1-Phosphatidylinositol 3-kinase | Oxygenase | Overexpression | Inhibitors | Cell lines | Breast | Cyclooxygenase-2 | Colonization | Cell migration | Tumors | Cancer | Index Medicus
Journal Article
European Urology, ISSN 0302-2838, 04/2019, Volume 75, Issue 4, pp. 593 - 601
Non–muscle-invasive bladder cancer (NMIBC) has a significant risk of recurrence despite adjuvant intravesical therapy. To determine whether celecoxib, a... 
Cardiovascular events | Cyclo-oxygenase 2 inhibitor | Bladder cancer | Chemoprevention | Randomised trial | APOPTOSIS | GUIDELINES | RISK | CANCER | ASPIRIN | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | UROLOGY & NEPHROLOGY | RECURRENCE | QUALITY-OF-LIFE | EXPRESSION | PROGRESSION | Celecoxib - administration & dosage | Humans | Middle Aged | Antibiotics, Antineoplastic - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclooxygenase 2 Inhibitors - adverse effects | Time Factors | Urinary Bladder Neoplasms - pathology | Female | Celecoxib - adverse effects | Mitomycin - adverse effects | Double-Blind Method | Risk Assessment | Cyclooxygenase 2 Inhibitors - administration & dosage | Risk Factors | Neoplasm Recurrence, Local | Treatment Outcome | United Kingdom | Urinary Bladder Neoplasms - drug therapy | Disease Progression | Antibiotics, Antineoplastic - administration & dosage | Carcinoma, Transitional Cell - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | BCG Vaccine - adverse effects | Carcinoma, Transitional Cell - drug therapy | Quality of Life | Aged | Cardiovascular Diseases - chemically induced | Administration, Intravesical | Neoplasm Staging | Mitomycin - administration & dosage | BCG Vaccine - administration & dosage | COX-2 inhibitors | Evaluation | Analysis | Oncology, Experimental | Adjuvant treatment | Clinical trials | Celecoxib | Angiogenesis inhibitors | Research | Standards | Cancer
Journal Article
Biochemical Journal, ISSN 0264-6021, 04/2011, Volume 435, Issue 2, pp. 431 - 439
Journal Article
Biochemical Journal, ISSN 0264-6021, 10/2005, Volume 391, Issue 2, pp. 441 - 448
Journal Article
REVUE DES MALADIES RESPIRATOIRES, ISSN 0761-8425, 02/2018, Volume 35, Issue 2, pp. 149 - 159
The Fernand Widal syndrome is a set of associations between asthma, nasal polyposis and aspirin sensitivity. Selective cyclo-oxygenase 2 (COX 2) inhibitors are... 
METAANALYSIS | INTOLERANCE | Celecoxib | PREVALENCE | Aspirin-induced asthma | Oral provocation test | Cyclo-oxygenase 2 | SENSITIVE PATIENTS | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | RESPIRATORY SYSTEM | CROSS-REACTIVITY | HYPERSENSITIVITY REACTIONS | EXACERBATED RESPIRATORY-DISEASE | Aspirin hypersensitivity | ANAPHYLAXIS
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 09/2000, Volume 131, Issue 1, pp. 152 - 159
Interleukin‐1 (IL‐1) is an important mediator of immunoinflammatory responses in the brain. In the present study, we examined whether prostaglandin E 2 (PGE 2... 
mitogen activated protein kinases | Interleukin‐1β | cyclo‐oxygenase‐2 | murine astrocytes | prostaglandin E | protein kinase C | Cyclo-oxygenase-2 | Mitogen activated protein kinases | Murine astrocytes | Protein kinase C | Interleukin-1β | prostaglandin E2 | Papers | cyclo-oxygenase-2
Journal Article
Molecular Therapy - Nucleic Acids, ISSN 2162-2531, 03/2019, Volume 14, pp. 262 - 273
Development of the receptive endometrium (RE) from the pre-receptive endometrium (PE) is essential for embryo implantation, but its molecular mechanisms have... 
EECs | ceRNA | endometrial epithelial cells | receptive endometrium | ciR8073-miR181a-NTS | dairy goats | MEDICINE, RESEARCH & EXPERIMENTAL | GENE-EXPRESSION PROFILES | RNAS | ESTROGEN | DEATH | MICRORNAS | DYSFUNCTION | IDENTIFICATION | CANCER | ENDOTHELIAL GROWTH-FACTOR
Journal Article
Journal Article
Journal Article
Journal Article